Literature DB >> 20160490

Negative regulation of CHK2 activity by protein phosphatase 2A is modulated by DNA damage.

Alyson K Freeman1, Virna Dapic, Alvaro N A Monteiro.   

Abstract

Checkpoint kinase 2 (CHK2) is a major effector of the DNA damage response pathway and although its mechanism of activation has been well studied, the attenuation of its activity following DNA damage has not been explored. Here, we identify the B'alpha subunit of protein phosphatase 2A (PP 2A) as a CHK2 binding partner and show that their interaction is modulated by DNA damage. B'alpha binds to the SQ/TQ repeat region of CHK2, which is a target of ATM phosphorylation. The induction of DNA double-strand breaks by gamma irradiation as well as treatment with doxorubicin causes dissociation of the B'alpha and CHK2 proteins. This dissociation correlates with an increase in the ATM-dependent phosphorylation of CHK2 at serines 33 and 35 in the SQ/TQ region. Indeed, mutating these sites to mimic phosphorylation increases the dissociation after irradiation. PP 2A negatively regulates CHK2 phosphorylation at multiple sites, as well as its kinase activity. These data reveal a novel mechanism for PP 2A to keep CHK2 inactive under normal conditions while also allowing for a rapid release from this regulation immediately following DNA damage. This is followed by a subsequent reconstitution of the PP 2A/CHK2 complex in later time points after damage, which may help to attenuate the signal.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20160490      PMCID: PMC3040716          DOI: 10.4161/cc.9.4.10613

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  51 in total

1.  A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.

Authors:  Pia Vahteristo; Jirina Bartkova; Hannaleena Eerola; Kirsi Syrjäkoski; Salla Ojala; Outi Kilpivaara; Anitta Tamminen; Juha Kononen; Kristiina Aittomäki; Päivi Heikkilä; Kaija Holli; Carl Blomqvist; Jiri Bartek; Olli-P Kallioniemi; Heli Nevanlinna
Journal:  Am J Hum Genet       Date:  2002-07-28       Impact factor: 11.025

2.  Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain.

Authors:  Joon-Young Ahn; Xianghong Li; Heather L Davis; Christine E Canman
Journal:  J Biol Chem       Date:  2002-03-18       Impact factor: 5.157

Review 3.  CHK2 kinase--a busy messenger.

Authors:  J Bartek; J Falck; J Lukas
Journal:  Nat Rev Mol Cell Biol       Date:  2001-12       Impact factor: 94.444

4.  Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.

Authors:  J Falck; C Lukas; M Protopopova; J Lukas; G Selivanova; J Bartek
Journal:  Oncogene       Date:  2001-09-06       Impact factor: 9.867

5.  Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation.

Authors:  Magtouf Gatei; Katie Sloper; Claus Sorensen; Randi Syljuäsen; Jacob Falck; Karen Hobson; Kienan Savage; Jiri Lukas; Bin-Bing Zhou; Jiri Bartek; Kum Kum Khanna
Journal:  J Biol Chem       Date:  2003-02-14       Impact factor: 5.157

6.  Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.

Authors:  Hanne Meijers-Heijboer; Ans van den Ouweland; Jan Klijn; Marijke Wasielewski; Anja de Snoo; Rogier Oldenburg; Antoinette Hollestelle; Mark Houben; Ellen Crepin; Monique van Veghel-Plandsoen; Fons Elstrodt; Cornelia van Duijn; Carina Bartels; Carel Meijers; Mieke Schutte; Lesley McGuffog; Deborah Thompson; Douglas Easton; Nayanta Sodha; Sheila Seal; Rita Barfoot; Jon Mangion; Jenny Chang-Claude; Diana Eccles; Rosalind Eeles; D Gareth Evans; Richard Houlston; Victoria Murday; Steven Narod; Tamara Peretz; Julian Peto; Catherine Phelan; Hong Xiang Zhang; Csilla Szabo; Peter Devilee; David Goldgar; P Andrew Futreal; Katherine L Nathanson; Barbara Weber; Nazneen Rahman; Michael R Stratton
Journal:  Nat Genet       Date:  2002-04-22       Impact factor: 38.330

7.  Chk2 activation and phosphorylation-dependent oligomerization.

Authors:  Xingzhi Xu; Lyuben M Tsvetkov; David F Stern
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

8.  Autophosphorylation of checkpoint kinase 2 at serine 516 is required for radiation-induced apoptosis.

Authors:  Xianglin Wu; Junjie Chen
Journal:  J Biol Chem       Date:  2003-07-09       Impact factor: 5.157

Review 9.  Chk1 and Chk2 kinases in checkpoint control and cancer.

Authors:  Jiri Bartek; Jiri Lukas
Journal:  Cancer Cell       Date:  2003-05       Impact factor: 31.743

10.  Karyopherin-alpha2 protein interacts with Chk2 and contributes to its nuclear import.

Authors:  Laura Zannini; Daniele Lecis; Sofia Lisanti; Roberta Benetti; Giacomo Buscemi; Claudio Schneider; Domenico Delia
Journal:  J Biol Chem       Date:  2003-08-09       Impact factor: 5.157

View more
  12 in total

Review 1.  What goes on must come off: phosphatases gate-crash the DNA damage response.

Authors:  Dong-Hyun Lee; Dipanjan Chowdhury
Journal:  Trends Biochem Sci       Date:  2011-09-18       Impact factor: 13.807

Review 2.  Mechanistic insight into DNA damage and repair in ischemic stroke: exploiting the base excision repair pathway as a model of neuroprotection.

Authors:  Peiying Li; Xiaoming Hu; Yu Gan; Yanqin Gao; Weimin Liang; Jun Chen
Journal:  Antioxid Redox Signal       Date:  2010-12-02       Impact factor: 8.401

3.  Charting the landscape of tandem BRCT domain-mediated protein interactions.

Authors:  Nicholas T Woods; Rafael D Mesquita; Michael Sweet; Marcelo A Carvalho; Xueli Li; Yun Liu; Huey Nguyen; C Eric Thomas; Edwin S Iversen; Sylvia Marsillac; Rachel Karchin; John Koomen; Alvaro N A Monteiro
Journal:  Sci Signal       Date:  2012-09-18       Impact factor: 8.192

4.  CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

Authors:  C García-Limones; M Lara-Chica; C Jiménez-Jiménez; M Pérez; P Moreno; E Muñoz; M A Calzado
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

5.  Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.

Authors:  Maike Zimmermann; Aruni S Arachchige-Don; Michaela S Donaldson; Robert F Dallapiazza; Colleen E Cowan; Mary C Horne
Journal:  J Biol Chem       Date:  2012-05-15       Impact factor: 5.157

6.  Phosphatases in the cellular response to DNA damage.

Authors:  Alyson K Freeman; Alvaro Na Monteiro
Journal:  Cell Commun Signal       Date:  2010-09-22       Impact factor: 5.712

Review 7.  CHK2 kinase in the DNA damage response and beyond.

Authors:  Laura Zannini; Domenico Delia; Giacomo Buscemi
Journal:  J Mol Cell Biol       Date:  2014-11-17       Impact factor: 6.216

8.  The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response.

Authors:  Anna Brestovitsky; Keren Nebenzahl-Sharon; Peter Kechker; Rakefet Sharf; Tamar Kleinberger
Journal:  PLoS Pathog       Date:  2016-02-11       Impact factor: 6.823

9.  Response to DNA damage: why do we need to focus on protein phosphatases?

Authors:  Midori Shimada; Makoto Nakanishi
Journal:  Front Oncol       Date:  2013-01-31       Impact factor: 6.244

Review 10.  Protein phosphatase 2A - structure, function and role in neurodevelopmental disorders.

Authors:  Priyanka Sandal; Chian Ju Jong; Ronald A Merrill; Jianing Song; Stefan Strack
Journal:  J Cell Sci       Date:  2021-07-06       Impact factor: 5.235

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.